China
· Delayed Price · Currency is CNY Qingdao Baheal Medical INC. Company Description
Qingdao Baheal Medical INC. engages in research and development, production, and sale of pharmaceutical products. The company offers bone health drugs under the D-Cal brand name; digestive drugs under Mite brand name ; liver disease drugs under the Fuzhenghuayu brand name ; and urological drugs the Betanli, Harle, and Wei Xi Kang brand name; It also provide ophthalmic drugs under the HYCOSAN brand name ; tumor and other severe drugs under the Human Albumin and Xospata brand; anti-aging and cosmeceuticals under the Quanis, Excellula, TRANSINO, Qingchunbao; diabetes drugs under the Naida, Feburic, and Naite brand; respiratory and anti-infective under the Klacid brand; medical nutrition under the Nutrasumma brand name.
The company was founded in 2005 and is based in Qingdao, China.
| Country | China |
| Founded | 2005 |
| Industry | Medical Distribution |
| Sector | Healthcare |
| Employees | 3,064 |
| CEO | Gang Fu |
Contact Details
Address: No. 88 Kaifeng Road Qingdao, 250000 China | |
| Phone | 86 53 26675 6688 |
| Website | baheal.cn |
Stock Details
| Ticker Symbol | 301015 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100004LR8 |
| SIC Code | 5122 |
Key Executives
| Name | Position |
|---|---|
| Gang Fu | Chairman and GM |
| Yuan Zhang | Deputy GM and Director |
| Feng Liu | Accounting Supervisor |
| Xiaowei Zhu | Deputy GM and Director |